BACKGROUND Herpetic necrotizing retinitis is a well-recognized entity. A few cases of herpetic non-necrotizing retinitis were previously reported. FINDINGS We retrospectively report two cases of herpetic non-necrotizing retinopathy with a long follow-up. A 19-year-old woman presented with a bilateral diffuse occlusive retinal vasculitis, peripheral neovascularization, and no signs of retinal ...

Background: Polypharmacy is the use of five or more types drugs in a therapy simultaneously. The polypharmacy increases potential for drug-drug interactions. In COVID-19 therapy, varied antiviral and non-antiviral medications allow increased drug Objective: To determine relationship between interactions therapy. Method: This an analytical observational study with retrospective data retrieval us...

Recurrence of hepatitis C virus (HCV) infection following liver transplantation is a major source of morbidity and mortality. The natural history of hepatitis C in the transplant setting is shortened. Overall, one third of HCV-infected recipients have developed allograft cirrhosis due to HCV recurrence by the 5th-7th year post-transplantation. The most significant variables which determine dise...

In this new era of highly effective oral antiviral drugs for chronic hepatitis C virus (HCV), indications for antiviral treatment may be extendable. This study undertaken to identify suitable candidates for peg-interferon plus ribavirin (PEG-IFN/RBV) treatment by evaluating hepatocellular carcinoma (HCC) risk in patients with chronic HCV treated or not with PEG-IFN/RBV.This large-scale retrospe...

background immunomodulators and nucleotide analogues have been used globally for the dealing of chronic hepatitis b virus (hbv) infection. however, the development of drug resistance is a major limitation to their long-term effectiveness. objectives the aim of this study was to characterize the hepatitis b virus reverse transcriptase (rt) protein variations among iranian chronic hbv carriers wh...

The aim of this review is to summarize the safety profile of the five approved oral nucleoside analogs used to treat chronic hepatitis B virus (HBV) infection, focusing on both the class adverse effects and those that have been reported with individual agents, as well as their safety in pregnancy. All nucleoside analogs have a "Black Box" warning because of their potential for inhibition of hum...